
iSIMPATHY
@iSIMPATHY
Followers
596
Following
263
Media
55
Statuses
229
An @SEUPB funded project which supported people to live healthy and active lives through the provision of Medicine Reviews. The project ended in March 2023.
Joined March 2020
After 3.5 years, the iSIMPATHY project ended on 31st March 2023. The project has transformed the approach to optimisation of medicines through the delivery of medicine reviews.
1
15
37
RT @scotgovhealth: Our project evaluation highlights how @iSIMPATHY improved patient outcomes and safety whilst delivering significant bene….
0
8
0
Our project evaluation is released today highlighting how @iSIMPATHY improved patient outcomes and safety whilst delivering significant benefits for the wider healthcare system. Read at: @SEUPB @MOICNI @HSELive @AlpanaMair @ciarakirke.@drmichaelscott1.
isimpathy.eu
Optimising patient medication outcomes whilst minimising harm.
0
13
29
We’re delighted @iSIMPATHY was recognised with the @RCSEd & @SurgeonsQuarter Health and Wellbeing Award at the #causewayawards2023 for our work highlighting the benefits of Medicine Reviews @SEUPB @MOICNI @HSELive @AlpanaMair @ciarakirke @drmichaelscott1 @RealisticMed.
Small Business Minister @richardlochhead presented the Health and Wellbeing Award to @isimpathy at the #CausewayAwards2023, which celebrates outstanding business achievements across Scotland, Ireland, and Northern Ireland.
1
3
15
RT @ciarakirke: Such a pleasure to talk #MedicationWithoutHarm and #medsafety with Andalusian hospital #pharmacists @safh_info. Sharing @WH….
0
4
0
RT @ALLIANCECarerVo: The @iSIMPATHY project sought to reduce the harm to patients taking multiple medicines and reduce waste, through 'Medi….
alliance-scotland.org.uk
Medicines are the most common healthcare intervention used within the health system, and the use of the right medicine for the right patient at the right time is central to this. For many people,...
0
9
0
You can keep up to date with future developments on the project website
isimpathy.eu
Optimising patient medication outcomes whilst minimising harm.
1
0
3